Healthcare
Dr. Agarwals Health Care Ltd
AGARWALEYE · NSE · INE943P01029Wednesday, 9 Sept 202612:16 pm
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE8.6%
ROCE7.2%
ROE8.6%
1Y Return+3.15%
Avg. Volume2.0M
Price Chart
52-Week Range
About
Dr. Agarwals Health Care Ltd is a Healthcare company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap—
Current Price₹515.85
52W High / Low₹568 / ₹401
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE8.6%
1Y Return+3.15%
Day Change-0.78%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹2,207 Cr | ₹2,080 Cr | ₹1,711 Cr | |||||
| Expenses | ₹1,595 Cr | ₹1,511 Cr | ₹1,248 Cr | |||||
| Operating Profit | ₹612 Cr | ₹570 Cr | ₹463 Cr | |||||
| OPM % | 28.0% | 27.0% | 27.0% | |||||
| Other Income | ₹39 Cr | ₹46 Cr | ₹43 Cr | |||||
| Depreciation | ₹292 Cr | ₹276 Cr | ₹231 Cr | |||||
| Interest | ₹89 Cr | ₹90 Cr | ₹115 Cr | |||||
| Profit Before Tax | ₹270 Cr | ₹249 Cr | ₹160 Cr | |||||
| Tax | ₹85 Cr | ₹81 Cr | ₹50 Cr | |||||
| Net Profit | ₹185 Cr | ₹168 Cr | ₹110 Cr | |||||
| EPS (₹) | 4.7 | 4.2 | 2.6 | |||||
| Dividend Payout % | — | 0% | 0% |
Financial history locked
Register freeRegister free to see 5 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹614 Cr | ₹564 Cr | ₹530 Cr | ₹499 Cr | |||||||
| Expenses | ₹444 Cr | ₹403 Cr | ₹386 Cr | ₹363 Cr | |||||||
| Operating Profit | ₹170 Cr | ₹161 Cr | ₹144 Cr | ₹136 Cr | |||||||
| OPM % | 28.0% | 29.0% | 27.0% | 27.0% | |||||||
| Depreciation | ₹78 Cr | ₹77 Cr | ₹69 Cr | ₹68 Cr | |||||||
| Interest | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹23 Cr | |||||||
| Net Profit | ₹55 Cr | ₹50 Cr | ₹44 Cr | ₹36 Cr | |||||||
| EPS (₹) | 1.4 | 1.3 | 1.1 | 0.9 |
Quarterly history locked
Register freeRegister free to see 7 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹32 Cr | ₹32 Cr | ₹9 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹1,994 Cr | ₹1,835 Cr | ₹1,330 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹1,066 Cr | ₹961 Cr | ₹966 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹850 Cr | ₹837 Cr | ₹446 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹3,942 Cr | ₹3,665 Cr | ₹2,751 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹2,879 Cr | ₹2,523 Cr | ₹1,746 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹152 Cr | ₹264 Cr | ₹471 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹676 Cr | ₹724 Cr | ₹416 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹3,942 Cr | ₹3,665 Cr | ₹2,751 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 5 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹519 Cr | ₹-308 Cr | ₹-220 Cr | ₹-10 Cr |
| FY25 | ₹360 Cr | ₹-750 Cr | ₹382 Cr | ₹-8 Cr |
| FY24 | ₹346 Cr | ₹-914 Cr | ₹553 Cr | ₹-15 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 |
Cash flow history locked
Register freeRegister free to see 5 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Fabtech Technologies Ltd | ₹656 Cr | 13.5 | +12.5% | -21.51% |
| Fischer Medical Ventures Ltd | — | — | +8.59% | -10.66% |
| Inventurus Knowledge Solutions Ltd | — | — | +31.4% | +7.00% |
| Indegene Ltd | — | — | +14.4% | +14.54% |
| Krsnaa Diagnostics Ltd | ₹1,833 Cr | 18.8 | +10.9% | -23.02% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-09-10Canada's major General Contractors unite to raise awareness about mental health problems and illnesses and prevent suicide across the construction industryCNW Group2026-08-31Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)StockStory2026-08-30The Roth Conversion That Cost a 62-Year-Old His $9,600 Health Insurance Subsidy24/7 Wall St.2026-08-30Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors ThinkMotley Fool2026-08-29Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE Filing
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.